About
PET agents, Radiopharmaceuticals
Areas of Focus
Categories
Medical Imaging TechnologyRadiopharmaceuticals
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
620
By Phase
PHASE3: 2PHASE2: 1PHASE1/PHASE2: 1PHASE1: 2
By Status
ACTIVE_NOT_RECRUITING: 3RECRUITING: 1TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05936658Lead Sponsor
[18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer
PHASE3Active, not recruiting
138 participants
Started: May 8, 2023 · Completed: Jun 30, 2025
NCT05579184Lead Sponsor
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2
PHASE2Active, not recruiting
20 participants
Started: Oct 30, 2022 · Completed: Dec 31, 2024
NCT05458544Lead Sponsor
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
PHASE1/PHASE2Recruiting
26 participants
Started: Sep 1, 2022 · Completed: Jun 1, 2025
NCT05004285Lead Sponsor
Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis
PHASE3Active, not recruiting
398 participants
Started: Apr 28, 2021 · Completed: Jun 1, 2025
NCT04528199Collaborator
[18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer
PHASE1Terminated
8 participants
Started: Feb 1, 2021 · Completed: Apr 21, 2023
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...